The global facial erythema treatment market is projected to expand at a 5.1% CAGR during the projection period, from a value of US$ 173.3 million in 2022 to US$ 299 million by 2032. The demand for treatment of facial erythema is projected to increase due to the expanding patient population, significant pipeline medications, and other …
Continue reading “Facial Erythema Treatment Market is expected to US$ 299 million by 2032”